Factors associated with surgical site infection after lower extremity bypass in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI)

Journal of Vascular Surgery

Volumn 60, Issue 5, 2014, Pages 1238-1246

  Kalish, Jeffrey A ^a   Farber, Alik ^a   Homa, Karen ^b   Trinidad, Magdiel ^c   Beck, Adam ^d   Davies, Mark G ^e   Kraiss, Larry W ^f   Cronenwett, Jack L ^g  

^a BOSTON MEDICAL CENTER   (United States)

^b Patient Safety Education Project   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF FLORIDA HEALTH   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BYPASS SURGERY; CARDIAC CONDUIT; DIALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INCISION; INFECTION RISK; LOWER EXTREMITY BYPASS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OBESITY; OPERATION DURATION; OPERATIVE BLOOD LOSS; PRIORITY JOURNAL; REGISTER; SOCIETY FOR VASCULAR SURGERY VASCULAR QUALITY INITIATIVE REGISTRY; SURGICAL INFECTION; BLOOD TRANSFUSION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CLUSTER ANALYSIS; COMORBIDITY; HEALTH CARE QUALITY; INFECTION CONTROL; LEG; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERIPHERAL VASCULAR DISEASES; PROCEDURES; RETROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICAL MODEL; SURGICAL WOUND INFECTION; TIME; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGERY; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; CHLORHEXIDINE; CLUSTER ANALYSIS; COMORBIDITY; FEMALE; HUMANS; INFECTION CONTROL; LOGISTIC MODELS; LOWER EXTREMITY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OPERATIVE TIME; PERIPHERAL VASCULAR DISEASES; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 84924720256     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.05.012     Document Type: Article

References (41)

1. Kent KC, Bartek S, Kuntz KM, Anninos E, Skillman JJ. Prospective study of wound complications in continuous infrainguinal incisions after lower limb arterial reconstruction: Incidence, risk factors, and cost. Surgery 1996;119:378-83
2. McPhee JT, Barshes NR, Ho KJ, Madenci A, Ozaki CK, Nguyen LL, et al. Predictive factors of 30-day unplanned readmission after lower extremity bypass. J Vasc Surg 2013;57:955-62
3. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet 2005;366:1925-34
4. Centers for Medicare and Medicaid Services. Application of incentives to reduce avoidable readmissions to hospitals. Fed Regist 2008;73: 23673-5
5. Centers forMedicare andMedicaid Services.Hospital-acquired conditions (HAC) in acute inpatient prospective payment system (IPPS) Hospitals. Fact sheet. Available at: http://www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/HospitalAcqCond/downloads/hacfactsheet.pdf. Accessed February 13, 2014
6. Greenblatt DY, Rajamanickam V, Mell MW. Predictors of surgical site infection after open lower extremity revascularization. J Vasc Surg 2011;54:433-9
7. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al; PREVENT III Investigators. Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006;43: 742-51
8. Nguyen LL, Brahmanandam S, Bandyk DF, Belkin M, Clowes AW, Moneta GL, et al. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: An analysis of 1404 operations for critical limb ischemia. J Vasc Surg 2007;46: 1191-7
9. Giles KA, Hamdan AD, Pomposelli FB, Wyers MC, Siracuse JJ, Schermerhorn ML. Body mass index: Surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg 2010;24: 48-56
10. Ramdev P, Rayan SS, Sheahan M, Hamdan AD, Logerfo FW, Akbari CM, et al. A decade experience with infrainguinal revascularization in a dialysis-dependent patient population. J Vasc Surg 2002;36: 969-74
11. Virkkunen J, Heikkinen M, Lepantalo M, Metsänoja R, Salenius JP; Finnvasc Study Group. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg 2004;40:761-7
12. Tan TW, Farber A, Hamburg NM, Eberhardt RT, Rybin D, Doros G, et al. Blood transfusion for lower extremity bypass is associated with increased wound infection and graft thrombosis. J Am Coll Surg 2013;216:1005-14
13. O'Keeffe SD, Davenport DL, Minion DJ, Sorial EE, Endean ED, Xenos ES. Blood transfusion is associated with increased morbidity and mortality after lower extremity revascularization. J Vasc Surg 2010;51: 616-21
14. Tan TW, Kalish JA, Hamburg NM, Rybin D, Doros G, Eberhardt RT, et al. Shorter duration of femoral-popliteal bypass is associated with decreased surgical site infection and shorter hospital length of stay. J Am Coll Surg 2012;215:512-8
15. Cronenwett JL, Kraiss LW, Cambria RP. The Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg 2012;55:1529-37
16. Cronenwett JL, Liksoky DS, Russell MT, Eldrup-Jorgensen J, Stanley AC, Nolan BW, et al. A regional registry for quality assurance and improvement: The Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg 2007:1093-102
17. Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford C, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-52
18. Leal-Noval SR, Rincón-Ferrari MD, García-Curiel A, Herruzo- Avilés A, Camacho-Laraña P, Garnacho-Montero J, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461-8
19. Fariñas MC, Gald Peralta F, Bernal JM, Rabasa JM, Revuelta JM, González-Macías J. Suppurative mediastinitis after open-heart surgery: A case-control study covering a seven-year period in Santander, Spain. Clin Infect Dis 1995;23:272-9
20. Chelemer SB, Prato S, Cox PM Jr, O'Connor GT, Morton JR. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002;73:138-42
21. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): An update. Blood Rev 2007;21:327-48
22. Blumberg N, Heal JM. Immunomodulation by blood transfusion: An evolving scientific and clinical challenge. Am J Med 1996;101: 299-308
23. Culver DH, Horan TC, Gaynes RP, Nartone WJ, Jarvis WR, Emori TG, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991;91: 152-7S
24. Cruse PJ, Foord R. A five-year prospective study of 23,649 surgical wounds. Arch Surg 1973;107:206-10
25. Campbell DA Jr, Henderson WG, Englesbe MJ, Hall BL, O'Reilly M, Bratzler D, et al. Surgical site infection prevention: The importance of operative duration and blood transfusiondresults of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg 2008;207:810-20
26. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke- Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362:9-17
27. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010;362:18-26
28. Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006;355:2640-51
29. Mohri Y, Tonouchi H, Kobayashi M, Nakai K, Kusunoki M. Mie Surgical Infection Research Group. Randomized clinical trial of singleversus multiple-dose antimicrobial prophylaxis in gastric cancer surgery. Br J Surg 2007;94:683-8
30. Uchiyama K, Takifuji K, Tani M, Ueno M, Kawai M, Ozawa S, et al. Prevention of postoperative infections by administration of antimicrobial agents immediately before surgery for patients with gastrointestinal cancers. Hepatogastroenterology 2007;54:1487-93
31. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2012;9:CD004985
32. Tanner J, Woodings D, Moncaster K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev 2006;3: CD004122
33. Levin I, Amer-Alshiek J, Avni A, Lessing JB, Satel A, Almog B. Chlorhexidine and alcohol versus povidone-iodine for antisepsis in gynecological surgery. J Womens Health (Larchmt) 2011;20:321-4
34. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis. Ann Intern Med 2002;136:792-801
35. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheterrelated infections. Infect Control Hosp Epidemiol 2002;23:759-69
36. Denton GW. Chlorhexidine. In: Block SS, editor. Disinfection, sterilization, and preservation. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 321-36
37. Culligan PJ, Kubik K, Murphy M, Blackwell L, Snyder J. A randomized trial that compared povidone iodine and chlorhexidine as antiseptics for vaginal hysterectomy. Am J Obstet Gynecol 2005;192:422-5
38. Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am 2005;87:980-5
39. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132
40. Goodney PP, Schanzer A, Demartino RR, Nolan BW, Hevelone ND, Conte MS, et al; Vascular Study Group of New England. Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg 2011;54:100-8
41. Woo K, Eldrup-Jorgensen J, Hallett JW, Davies MG, Beck A, Upchurch GR Jr, et al; Vascular Quality Initiative. Regional quality groups in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg 2013;57:884-90.